In a study published in Gastroenterology, more than 1,700 patients with confirmed family or past history of CRC were followed for surveillance. In the 1,071 patients who returned at least one fecal immunochemical test after colonoscopies, the test detected 12 out of 14 cancers and 60 out of 96 advanced adenomas. Positive FIT tests also led to diagnosis made sooner by 25 months for cancer and by 24 months for advanced adenomas before regularly scheduled colonoscopies.
Using fecal occult blood tests at regular internals between colonoscopies is recommended as a strategy to manage risk of CRC.
Read the news release about colorectal cancer screening for high-risk patients.
Read other coverage about colorectal cancer screening:
– CDC: 50% of CRC Cases are Detected in Late Stages
– New Research Supports Previous Studies Aspirin Reduces Risk of CRC
– Researchers Conduct Cost-Analysis of Study of Colorectal Cancer Screening Modalities
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.